Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Hematology Reports|September 1, 2005
Type 2N von Willebrand diseaseClaudine Mazurier, Lysiane HilbertHaematologica|September 21, 2004
A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implicationsLysiane Hilbert, Augusto B Federici, Luciano Baronciani, et al.British Journal of Haematology|May 18, 2006
Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand diseaseClaudine Caron, Lysiane Hilbert, Karen Vanhoorelbeke, et al.Thrombosis and Haemostasis|September 6, 2006
Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptideLysiane Hilbert, Paquita Nurden, Claudine Caron, et al.British Journal of Haematology|February 18, 2003
Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacityLysiane Hilbert, Sylvie Jorieux, Valérie Proulle, et al.Seminars in Thrombosis and Hemostasis|July 25, 2006
Composition, quality control, and labeling of plasma-derived products for the treatment of von Willebrand diseaseClaudine MazurierBlood|November 25, 2003
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European studyAugusto B Federici, Claudine Mazurier, Erik Berntorp, et al.International Journal of Hematology|February 15, 2002
Molecular genetics of type 2 von Willebrand diseaseEdith Fressinaud, Claudine Mazurier, Dominique MeyerBritish Journal of Haematology|May 25, 2002
Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagentsClaudine Caron, Claudine Mazurier, Jenny GoudemandThrombosis and Haemostasis|September 28, 2002
Standardisation of von Willebrand Factor in therapeutic concentrates: calibration of the 1st International Standard for von Willebrand Factor concentrate (00/514)Anthony R Hubbard, Dawn Sands, Andrew C Chang, et al.Pageof 3